Literature DB >> 17956974

Wild-type is the optimal sequence of the HDV ribozyme under cotranscriptional conditions.

Durga M Chadalavada1, Andrea L Cerrone-Szakal, Philip C Bevilacqua.   

Abstract

RNA viruses are responsible for a variety of human diseases, and the pathogenicity of RNA viruses is often attributed to a high rate of mutation. Self-cleavage activity of the wild-type hepatitis delta virus (HDV) ribozyme as measured in standard divalent ion renaturation assays is biphasic and mostly slow and can be improved by multiple rational changes to ribozyme sequence or by addition of chemical denaturants. This is unusual in the sense that wild type is the most catalytically active sequence for the majority of protein enzymes, and RNA viruses are highly mutable. To see whether the ribozyme takes advantage of fast-reacting sequence changes in vivo, we performed alignment of 76 genomic and 269 antigenomic HDV isolates. Paradoxically, the sequence for the ribozyme was found to be essentially invariant in nature. We therefore tested whether three ribozyme sequence changes that improve self-cleavage under standard divalent ion renaturation assays also improve self-cleavage during transcription. Remarkably, wild type was as fast, or faster, than these mutants under cotranscriptional conditions. Slowing the rate of transcription or adding the hepatitis delta antigen protein only further stimulated cotranscriptional self-cleavage activity. Thus, the relative activity of HDV ribozyme mutants depends critically on whether the reaction is assayed under in vivo-like conditions. A model is presented for how wild-type ribozyme sequence and flanking sequence work in concert to promote efficient self-cleavage during transcription. Wild type being the optimal ribozyme sequence under in vivo-like conditions parallels the behavior of most protein enzymes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17956974      PMCID: PMC2080589          DOI: 10.1261/rna.778107

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  42 in total

1.  General acid-base catalysis in the mechanism of a hepatitis delta virus ribozyme.

Authors:  S Nakano; D M Chadalavada; P C Bevilacqua
Journal:  Science       Date:  2000-02-25       Impact factor: 47.728

2.  Design of a highly reactive HDV ribozyme sequence uncovers facilitation of RNA folding by alternative pairings and physiological ionic strength.

Authors:  Trevor S Brown; Durga M Chadalavada; Philip C Bevilacqua
Journal:  J Mol Biol       Date:  2004-08-13       Impact factor: 5.469

3.  Self-cleavage of hepatitis delta virus genomic strand RNA is enhanced under partially denaturing conditions.

Authors:  S P Rosenstein; M D Been
Journal:  Biochemistry       Date:  1990-09-04       Impact factor: 3.162

4.  Characterization and application of the selective strand annealing activity of the N terminal domain of hepatitis delta antigen.

Authors:  Zhi-Shun Huang; Albert You-Ju Chen; Huey-Nan Wu
Journal:  FEBS Lett       Date:  2004-12-17       Impact factor: 4.124

Review 5.  RNA folding during transcription.

Authors:  Tao Pan; Tobin Sosnick
Journal:  Annu Rev Biophys Biomol Struct       Date:  2006

6.  Hepatitis delta antigen binds to the clamp of RNA polymerase II and affects transcriptional fidelity.

Authors:  Yuki Yamaguchi; Takashi Mura; Sittinan Chanarat; Sachiko Okamoto; Hiroshi Handa
Journal:  Genes Cells       Date:  2007-07       Impact factor: 1.891

Review 7.  Basic mechanisms of transcript elongation and its regulation.

Authors:  S M Uptain; C M Kane; M J Chamberlin
Journal:  Annu Rev Biochem       Date:  1997       Impact factor: 23.643

8.  Autophosphorylation sites participate in the activation of the double-stranded-RNA-activated protein kinase PKR.

Authors:  D R Taylor; S B Lee; P R Romano; D R Marshak; A G Hinnebusch; M Esteban; M B Mathews
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

9.  Folding of a large ribozyme during transcription and the effect of the elongation factor NusA.

Authors:  T Pan; I Artsimovitch; X W Fang; R Landick; T R Sosnick
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

10.  Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA.

Authors:  S Makino; M F Chang; C K Shieh; T Kamahora; D M Vannier; S Govindarajan; M M Lai
Journal:  Nature       Date:  1987 Sep 24-30       Impact factor: 49.962

View more
  25 in total

1.  The human HDV-like CPEB3 ribozyme is intrinsically fast-reacting.

Authors:  Durga M Chadalavada; Elizabeth A Gratton; Philip C Bevilacqua
Journal:  Biochemistry       Date:  2010-06-29       Impact factor: 3.162

Review 2.  Roles of DEAD-box proteins in RNA and RNP Folding.

Authors:  Cynthia Pan; Rick Russell
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

3.  Long-distance communication in the HDV ribozyme: insights from molecular dynamics and experiments.

Authors:  Narayanan Veeraraghavan; Philip C Bevilacqua; Sharon Hammes-Schiffer
Journal:  J Mol Biol       Date:  2010-07-17       Impact factor: 5.469

4.  The fraction of RNA that folds into the correct branched secondary structure determines hepatitis delta virus type 3 RNA editing levels.

Authors:  Sarah D Linnstaedt; Wojciech K Kasprzak; Bruce A Shapiro; John L Casey
Journal:  RNA       Date:  2009-04-21       Impact factor: 4.942

5.  Mechanistic characterization of the HDV genomic ribozyme: the cleavage site base pair plays a structural role in facilitating catalysis.

Authors:  Andrea L Cerrone-Szakal; Durga M Chadalavada; Barbara L Golden; Philip C Bevilacqua
Journal:  RNA       Date:  2008-07-24       Impact factor: 4.942

6.  A Two-Metal-Ion-Mediated Conformational Switching Pathway for HDV Ribozyme Activation.

Authors:  Tai-Sung Lee; Brian K Radak; Michael E Harris; Darrin M York
Journal:  ACS Catal       Date:  2016-02-01       Impact factor: 13.084

7.  Probing fast ribozyme reactions under biological conditions with rapid quench-flow kinetics.

Authors:  Jamie L Bingaman; Kyle J Messina; Philip C Bevilacqua
Journal:  Methods       Date:  2017-03-14       Impact factor: 3.608

8.  A catalytic metal ion interacts with the cleavage Site G.U wobble in the HDV ribozyme.

Authors:  Jui-Hui Chen; Bo Gong; Philip C Bevilacqua; Paul R Carey; Barbara L Golden
Journal:  Biochemistry       Date:  2009-02-24       Impact factor: 3.162

9.  Efficient inhibition of hepatitis B virus replication by hepatitis delta virus ribozymes delivered by targeting retrovirus.

Authors:  Chuan-Xi Wang; Yan-Qin Lu; Peng Qi; Long-Hua Chen; Jin-Xiang Han
Journal:  Virol J       Date:  2010-03-17       Impact factor: 4.099

10.  Bridging the gap between in vitro and in vivo RNA folding.

Authors:  Kathleen A Leamy; Sarah M Assmann; David H Mathews; Philip C Bevilacqua
Journal:  Q Rev Biophys       Date:  2016-06-24       Impact factor: 5.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.